Published in Eur J Pharmacol on November 14, 1994
Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest (1998) 1.58
NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. Immunology (1999) 1.17
Nitric oxide and wound healing. World J Surg (2004) 1.09
Expression of inducible nitric oxide synthase and its involvement in pulmonary granulomatous inflammation in rats. Am J Pathol (1996) 0.96
Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5. Br J Pharmacol (2005) 0.88
Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model. Am J Pathol (2004) 0.85
Effect of kramecyne on the inflammatory response in lipopolysaccharide-stimulated peritoneal macrophages. Evid Based Complement Alternat Med (2013) 0.77
Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol (1971) 6.97
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature (1980) 4.29
Screens for anti-inflammatory drugs. J Pharm Pharmacol (1971) 3.24
Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ (2008) 2.84
Biological properties of carrageenan. J Pharm Pharmacol (1972) 2.58
Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol (1992) 2.32
Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun (1990) 2.31
A histopathological and pharmacological analysis of the mode of action of nonsteroidal anti-inflammatory drugs. J Pathol (1971) 2.15
Anti-phospholipase proteins. Prostaglandins (1984) 1.93
Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther (2000) 1.81
Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br J Pharmacol (1982) 1.74
Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol (1993) 1.72
A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology (1994) 1.54
Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol (1992) 1.45
Mesotheliomas following exposure to asbestos used in railroads: 130 Italian cases. Med Lav (1996) 1.38
Hydrocortisone-induced inhibitor of prostaglandin biosynthesis in rat leucocytes. Br J Pharmacol (1980) 1.36
The inhibition by hydrocortisone of prostaglandin biosynthesis in rat peritoneal leucocytes is correlated with intracellular macrocortin levels. Br J Pharmacol (1981) 1.34
Mechanism of inhibition of prostaglandin biosynthesis by hydrocortisone in rat leucocytes. Br J Pharmacol (1979) 1.34
Structural elucidation of a new cytotoxin isolated from mussels of the Adriatic sea. J Org Chem (2001) 1.30
Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br J Pharmacol (1995) 1.16
Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett (1997) 1.15
Inflammatory effects of Salmonella typhimurium porins. Infect Immun (1990) 1.14
Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in vivo. Eur J Pharmacol (1992) 1.11
Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages. J Clin Lab Anal (2005) 1.09
The mechanism of the inflammatory effect of carrageenin. Eur J Pharmacol (1968) 1.07
Some pharmacodynamic properties of carrageenin in the rat. Br J Pharmacol (1970) 1.03
Indomethacin and prostaglandins. Eur J Pharmacol (1972) 1.01
Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. Br J Pharmacol (1987) 1.01
Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J Clin Invest (1999) 1.01
Role of tumor necrosis factor-alpha in acute hypovolemic hemorrhagic shock in rats. Am J Physiol (1994) 1.00
Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol Lett (2007) 1.00
Evidence that mast cell degranulation, histamine and tumour necrosis factor alpha release occur in LPS-induced plasma leakage in rat skin. Br J Pharmacol (1999) 0.99
Multiple control of inflammation by glucocorticoids. Agents Actions (1986) 0.99
Leucocyte migration and lysosomal enzymes release in rat carrageenin pleurisy. Agents Actions (1975) 0.98
Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut (2006) 0.97
New cytotoxic steroids from the marine sponge Dysidea fragilis coming from the lagoon of Venice. Steroids (1995) 0.97
Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J Immunol (1999) 0.96
Hyaluronic acid modulates acute and chronic inflammation. Agents Actions (1994) 0.96
Non-steroidal anti-inflammatory drugs and leucocyte emigration. J Pharm Pharmacol (1972) 0.95
Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages. FEBS Lett (1998) 0.95
Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic. Eur Rev Med Pharmacol Sci (2013) 0.94
Enhancement of carrageenin foot oedema by 1,10 -phenanthroline and evidence for the bradykinin as endogenous mediator. Agents Actions (1975) 0.93
Role of cyclopentenone prostaglandins in rat carrageenin pleurisy. FEBS Lett (2001) 0.92
Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB. Br J Pharmacol (1998) 0.92
The anti-inflammatory effect of glucocorticoid-induced phospholipase inhibitory proteins. Agents Actions (1985) 0.92
Nitric oxide inhibits LPS-induced tumor necrosis factor synthesis in vitro and in vivo. Life Sci (1996) 0.91
Non-AIDS-defining cancers among HIV-infected people. Eur Rev Med Pharmacol Sci (2012) 0.91
In vitro interactions of PGE and cAMP with murine and human erythroid precursors. Blood (1980) 0.91
Bone disease in the setting of HIV infection: update and review of the literature. Eur Rev Med Pharmacol Sci (2013) 0.91
Socioeconomic determinants of influenza vaccination among older adults in Italy. Prev Med (2010) 0.89
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator. Cell Death Differ (2013) 0.89
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals. Eur Rev Med Pharmacol Sci (2013) 0.88
Action of prolactin, IFN-gamma, TNF-alpha and LPS on heme oxygenase-1 expression and VEGF release in human monocytes/macrophages. Int Immunopharmacol (2005) 0.88
Relationship between nitric oxide and prostaglandins in carrageenin pleurisy. Biochem Pharmacol (1998) 0.88
Endogenous nitric oxide modulates morphine-induced constipation. Biochem Biophys Res Commun (1991) 0.87
Nitric oxide inhibits leucocyte migration in carrageenin-induced rat pleurisy. Inflamm Res (2000) 0.87
Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides. Adv Prostaglandin Thromboxane Leukot Res (1983) 0.87
Kidney disease in HIV-infected patients. Eur Rev Med Pharmacol Sci (2013) 0.87
Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin rat paw oedema. Eur J Pharmacol (1995) 0.86
Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats. Eur J Pharmacol (1994) 0.86
Anti-inflammatory effects of vasocortin and nonapeptide fragments of uteroglobin and lipocortin I (antiflammins). Agents Actions (1990) 0.86
Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br J Pharmacol (1994) 0.85
Glycolipids from sponges. VII. Simplexides, novel immunosuppressive glycolipids from the Caribbean sponge Plakortis simplex. Bioorg Med Chem Lett (1999) 0.85
[Pharmacological research on a deethylate metabolite of 4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide (metoclopramide)]. Boll Chim Farm (1976) 0.85
HSF1/hsp72 pathway as an endogenous anti-inflammatory system. FEBS Lett (2001) 0.84
Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide. Shock (1997) 0.84
Expression of TGF-beta in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammation, IL-2 and IFN-gamma, but enhancement of IL-10, in carrageenin-induced oedema in mice. Immunology (1995) 0.84
Hepatocellular carcinoma in HIV positive patients. Eur Rev Med Pharmacol Sci (2012) 0.84
Cyclooxygenase-2-dependent generation of 8-epiprostaglandin F2alpha by lipopolysaccharide-activated J774 macrophages. Inflamm Res (1999) 0.84
Prostaglandins, leucocytes and non-steroidal anti-inflammatory drugs. Pol J Pharmacol Pharm (1974) 0.84
Differential effect of L-NAME and S-methyl-isothiourea on leukocyte emigration in carrageenin-soaked sponge implants in rat. Br J Pharmacol (1997) 0.82
Activation of nuclear transcription factor kappaB in rat carrageenin-induced pleurisy. Eur J Pharmacol (1999) 0.82
Opioids inhibit the induction of nitric oxide synthase in J774 macrophages. Biochem Biophys Res Commun (1995) 0.81
Prolactin induces chitotriosidase gene expression in human monocyte-derived macrophages. Immunol Lett (2004) 0.81
5,6-Dihydroxyindole-2-carboxylic acid, a diffusible melanin precursor, is a potent stimulator of lipopolysaccharide-induced production of nitric oxide by J774 macrophages. Life Sci (1995) 0.80
Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw. Gene Ther (2000) 0.80
Protective role of nuclear factor kappa B against nitric oxide-induced apoptosis in J774 macrophages. Cell Death Differ (2001) 0.80
Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse. Br J Pharmacol (1998) 0.80
Cytotoxic saponins from bulbs of Allium porrum L. J Agric Food Chem (2000) 0.80
Cloricromene inhibits the induction of nitric oxide synthase. Eur J Pharmacol (1993) 0.79
Selective inhibition by vasocortin of histamine release induced by dextran and concanavalin-A from rat peritoneal cells. Br J Pharmacol (1989) 0.79
Lipocortin and vasocortin: two species of anti-inflammatory proteins mimicking the effects of glucocorticoids. Pharmacol Res (1992) 0.79
Nitric oxide inhibits neutrophil infiltration in the reverse passive arthus reaction in rat skin. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.79
Role of nuclear factor-kappaB in a rat model of vascular injury. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.79
Role in inflammation of glucocorticoid-induced phospholipase inhibitory proteins. Prog Biochem Pharmacol (1985) 0.79
Nuclear factor-kappaB activation mediates inducible nitric oxide synthase expression in carrageenin-induced rat pleurisy. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.79